Exact Sciences (EXAS) Misses Q3 EPS by 1c
Tweet
Share
E-mailGet Alerts EXAS Hot Sheet
Price: $104.91 --0%
Financial Fact:
Loss from operations: -38.28M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Financial Fact:
Loss from operations: -38.28M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Exact Sciences (NASDAQ: EXAS) reported Q3 EPS of ($0.45), $0.01 worse than the analyst estimate of ($0.44). Revenue for the quarter came in at $12.6 million versus the consensus estimate of $12.56 million.
For earnings history and earnings-related data on Exact Sciences (EXAS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Activist investor presses Xerox to review financial services arm - Bloomberg
- Labcorp acquires MLM Medical Labs to expand lab network
- UBS upgrades Lockheed Martin to Buy, sees 26% upside on missile growth
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
